Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome)

Overview of attention for article published in Cochrane database of systematic reviews, February 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

So far, Altmetric has seen 1 news story.

Biotech company Actigen initiates a clinical development programme for GNR-055, a potentially breakthrough treatment for the…